| |||||
| | NJSHP Home | Join NJSHP | Meeting Dates | Career Center | Contact Us | | |||||
|
Announcements
2011 POSTER WINNERS
This year’s poster session was striking due to the remarkable participation of 22 institutions who submitted a total of 58 posters. Based on scientific merit and poster content, the following posters were judged as winners:
1st Place: The impact of a pharmacist-run medication claims denial and revenue recovery program within an integrated healthcare system: a two-year review
2nd Place: The impact of a pharmacist educating inpatients on new medications
3rd Place: Implementation of an antibiotic stewardship program using a real-time patient surveillance system Thank you to the judging time and talents of Drs. Deepali Dixit, Sudha Narayanaswami, Patricia O’Connor, Timothy Reilly, and Mary Wagner.
Headlines
NJSHP News
ASHP News
Pharmacy News
NJSHP News
2011 ANNUAL AWARDS
NJSHP wishes to congratulate the 2011 award recipients for their commitment to the profession and their exceptional service.
Gregory A. Santora – Pharmacist of the Year Leadership Award
Pharmacist Practitioner Award
The Pharmacy Technician Award Dean Sciarrone Student Award Lauren Faust, Pharmacy student at Rutgers University was the recipient of the student award. Lauren is the President of the NJSHP Rutgers Chapter who organized numerous NJSHP’s student events, and helped expand the students’ scope of the profession. Lauren positively influenced other students’ perceptions of pharmacy careers. She became the ASHP Student Liaison this year and helped the NJSHP Rutgers Chapter receive national recognition for the first time for its achievements. Lauren is working with other student leaders across the nation to help promote ASHP and health-systems pharmacy. Her goal is to let other schools and pharmacists use our organization as an example so they can recreate our events at their schools to further educate students.
2011 COLLEGE BOWL
This year’s college bowl brought together contestants from the Ernest Mario School of Pharmacy at Rutgers University, and the Arnold and Marie Schwartz College of Pharmacy at Long Island University. After two hours of non-stop enthusiasm and several tied scores, the intense competition ended with the big win of Rutgers University who earned the applauds and cheers of a very impressed audience with the wealth of the students’ knowledge.
Congratulations to all the winners (Natasha Advani, Andrew Davidson, Lauren Faust, Julius Li, and Astrela Sison) for their triumph, and thank you to all moderators, judges, and volunteers for making this event such a success.
Upcoming Seminars and Technician Seminars
North Chapter
May 31, 2011 Topic: Pathogenesis and Treatment of HIV Infection Location: St. Joseph’s Wayne Hospital – Mayer Conference Room Time: 6:30 PM – 8:30 PM Speaker: Nan Hong, PharmD, BCPS Infectious Disease Clinical Pharmacist St. Joseph’s Regional Medical Center Wayne, NJ
North Central Chapter
May 26, 2011
June 29, 2011
Southern Chapter
June 21, 2011
Technician Seminars
June 15, 2011 Anaphalactic Shock and Allergies (2 Credits)
June 21, 2011 Pain Management (2 Credits)
NJSHP Student Chapter April Report
Upcoming Events
Rutgers Day Booth, April 30th NJSHP is teaming up with APhA-ASP's Trooper Turtle committee to create a booth for the children visiting campus during Rutgers Day! The booth will focus on teaching children the danger associated with everyday poisons, such as household cleaning products, and what to do if they come into contact with a poison. NJSHP members will perform the skit from the poison prevention activity. March of Dimes, May 1st It will take place from 9AM - 12PM and start at the RAC on Livingston Campus. We will be walking about 6 miles around Rutgers University. We are teaming up with PDC for this event.
Recent Events
Visit our website www.njshprutgers.weebly.com gallery for pictures of our past events!
Please feel free to contact me via e-mail, laurenfaust@comcast.net or cell: 856-261-1128 with any questions or comments.
NJSHP Welcomes Disney Institute to Princeton on June 30, 2011
As a result, we have postponed Disney's Approach to Quality Service for Healthcare Professionals one-day event from March 17, 2011 to June 30, 2011. We apologize for the inconvenience. A one-day local workshop, Disney's Approach to Quality Service for Healthcare Professionals program will show you the importance of attention to detail in everything Disney does -- from training its Cast Members (employees) to treating every Guest (patient) as a VIP. You will hear the stories and see how Disney best practices can be easily adapted to your healthcare delivery organization. IMPORTANT: Please use promotional code SHPMNE to receive $35 OFF PER GUEST when registering. Additional group discounts are available. TO LEARN MORE AND REGISTER GO TO: www.PrincetonMouse.com No prerequisite training required.
ASHP News
ASHP Partners with HHS, Health Care Groups in New Patient Safety Initiative
4/13/2011 ASHP has joined the Department of Health and Human Services (HHS) and a group of leading hospital, provider, and patient groups in an effort to improve the quality, safety, and affordability of health care.
The Partnership for Patients aims to save more than 60,000 lives by stopping preventable injuries and complications. Prevention of adverse drug reactions is one of the areas targeted for attention. Research showing the benefits of involving pharmacists in patient care roles, including the recent study by ASHP member Marie Chisholm-Burns, is featured on the Partnership’s web site. ASHP will be working to help our members understand how to participate and take advantage of the Partnership.
Olmesartan's Benefits in Treating Hypertension Outweigh Potential Risks, FDA Says
Cheryl A. Thompson BETHESDA, MD 14 April 2011 — FDA, after reviewing the results of placebo-controlled studies that found higher rates of cardiovascular-related death in patients with type 2 diabetes mellitus who received olmesartan, has concluded that the benefits of the drug in patients with hypertension "continue to outweigh its potential risks."
The agency announced its finding today in a "drug safety communication." In June 2010 , FDA said it had undertaken a review of the data from the two Phase III studies, which focused on a medical use other than the treatment of hypertension. The agency at the time emphasized that it had not concluded that olmesartan therapy increases the risk of death. Results of the larger Phase III study, Randomized Olmesartan and Diabetes Microalbuminuria Prevention , appeared in the March 10 issue of the New England Journal of Medicine.
Ortho-McNeil Recalls Topamax 100-mg Tablets
Cheryl A. Thompson BETHESDA, MD 14 April 2011 — Ortho-McNeil Neurologics this morning announced a recall of lots 0KG110 and 0LG222 of Topamax 100-mg tablets because consumers have complained that the product has an uncharacteristic odor.
The company, a division of Ortho-McNeil-Janssen Pharmaceuticals Inc., said the odor may be caused by trace amounts of 2,4,6-tribromoanisole (TBA), a byproduct of a chemical preservative sometimes applied to the wood of pallets. Similar recalls of products from other Johnson & Johnson companies have been occurring for more than a year.
Pharmacy News
South College's New West Knoxville Campus Boosts Programs, Technology
PR Newswire (03/31/11) Rolan, Bennett
South College in Tennessee is scheduled to officially open a new campus today. The new South College campus will house a number of programs, including a new pharmacy school. The school is expected to create approximately 50 jobs within three years, and already employs 200 people. Thus far, campus is expected to have 280 students on campus as of fall 2010, out of a maximum capacity of 800 seats. South expects the remaining slots to be taken once programs reach full accreditation status, including the pharmacy school, which will admit 50 students initially, according to Accreditation Council for Pharmacy Education standards. The pharmacy program has capacity for 300 students after three years. "Starting classes is contingent upon us being granted precandidate status by the ACPE. We will know that in June and are planning to start classes on July 25," South College Dean of Pharmacy Walter Fitzgerald said.
Drug Shortages Cost Providers $200M Annually, Endanger Patient Safety
Becker's ASC Review (03/11) Fields, Rachel
The Premier healthcare alliance surveyed 311 hospital pharmacy experts from 228 hospitals and other facilities and found that 90 percent experienced a prescription drug shortage in 2010. At least a half-dozen drug shortages were reported by more than 50 percent of respondents, and the study indicates that these drug shortages cost hospitals $200 million or more per year. The survey shows that 80 percent of those polled said drug shortages caused a delay or cancellation of patient care intervention; 42 percent said they were forced to purchase a higher-priced product from a "gray market" vendor; and 60 percent said pharmacists were forced to compound a drug that was either unavailable or priced too high.
FDA Statement on Hydroxyprogesterone Caproate
FDA.gov (03/30/11)
The FDA has issued a notice regarding compounding of hydroxyprogesterone caproate (Makena). For many years, the FDA has permitted pharmacists to compound a version of the active ingredient in the drug, synthetic progestin, for physicians who requested it by exercising enforcement discretion. Because the drug is a sterile injectable, where there is a risk of contamination, greater assurance of safety is provided by an approved product. However, under certain conditions, a licensed pharmacist may compound a drug product using ingredients that are components of FDA approved drugs if the compounding is for an identified individual patient based on a valid prescription for a compounded product that is necessary for that patient. FDA prioritizes enforcement actions related to compounded drugs using a risk-based approach, giving the highest enforcement priority to pharmacies that compound products that are causing harm or that amount to health fraud. KV Pharmaceuticals, which manufactures hydroxyprogesterone caproate, recently sent letters to pharmacists indicating that the FDA will no longer exercise enforcement discretion with regard to compounded versions of their product, which is not the case. At this time, the FDA does not intend to change their policy regarding this product, and it does not intend to take enforcement action against pharmacies that compound hydroxyprogesterone caproate based on a valid prescription for an individually identified patient unless the compounded products are unsafe, of substandard quality, or are not being compounded in accordance with appropriate standards for compounding sterile products.
Promoting Hand Hygiene in Healthcare Through National/Subnational Campaigns
Journal of Hospital Infection (02/26/2011) Mathai, E.; Allegranzi, B.; Kilpatrick, C.
The World Health Organization (WHO) First Global Patient Safety Challenge first surveyed coordinated large-scale activities to improve healthcare hand hygiene in 2007. The investigators found that 20 nations and subnations had ongoing coordinated activities intended to promote hand hygiene in healthcare. In early 2009, when investigators repeated the survey, this number increased to 38 campaigns or program. Of these 38, 29 were active national/subnational-level initiatives and 22 had started after the launch of the WHO Challenge in October 2005. In both 2007 and 2009, larger hospitals--including general, district, and university hospitals--were in the main targets for these programs. According to the 2009 survey, only nine hand hygiene initiatives existed at the national/subnational level before the Challenge was launched. The researchers found that wider healthcare-associated infection prevention campaigns were more common than specific campaigns for hand hygiene, and more initiatives are addressing primary, long-term, and home care. The authors concluded that hand hygiene is being promoted in healthcare in many nations and subnations, though they note that "greater efforts are needed to encourage others to initiate and sustain such activities.
When It Comes to Top-Quality Heart Attack Care, Culture Matters
Wall Street Journal (03/15/11) Winslow, Ron
In a study published recently in the Annals of Internal Medicine, Yale researchers examined characteristics of hospitals in the top 5 percent and the bottom 5 percent with regard to heart attack care and their 30-day mortality rates. In interviews with staffers at 11 hospitals across the country, researchers found major differences in hospital management and quality improvement approaches but few differences in heart attack treatment. Leslie Curry of Yale's Global Health Leadership Institute, the study's lead author, says, "It's not so much what they're doing but how they're doing it." Hospitals with higher 30-day mortality rates had higher nurse turnover rates, while those with lower mortality rates viewed mistakes as learning experiences and valued the input of nurses, pharmacists, technicians and housekeeping staff. Curry says human interaction appears to matter more than investments in high-cost technology.
Diabetes Education Under-Used by Medicare Recipients
Diabetes Health (03/13/2011)
Qualified patients rarely use the Medicare-paid diabetes self-management education (DSMT), which provides important information and skills training for diabetes patients. DSMT helps patients identify barriers to wellness and develop coping skills for disease management. This can prevent or delay complications and reduce the healthcare burden of diabetes. However, few people with diabetes know about the availability of DSMT. Recent research from the American Association of Diabetes Educators says that about 8.5 million Americans covered by Medicare have diabetes, but only 58,000 of these individuals--less than 1 percent of those eligible--have received the educational services available through Medicare. This education is provided by diabetes educators already licensed in a healthcare specialty, including registered nurses, registered dietitians, or pharmacists.
Reform Sharpens Focus on Quality Outcomes
Health Leaders Magazine Online (03/11) Cantlupe, Joe
The federal healthcare reform law focuses on lowering medical costs and improving quality of care, implementing such innovations as accountable care organizations, robust electronic medical records and the medical home. Hospitals increasingly are enhancing quality by taking steps to lower readmission rates, shorten hospital stays, eliminate bloodstream infections, minimize medical errors and boost patient satisfaction. Hospital leaders have created leadership teams comprised of physicians, nurses, pharmacists and others to collaborate on efforts to achieve quality outcomes. "Coming to this new vision, it was very important that we engaged our medical staff in the process; our medical staff became partners in care," says William Mayer, MD, MPH, vice president and chief quality officer at Bronson Healthcare Group in Michigan. "We agreed that our primary customers were patients and families, and that was also an essential element of focusing our quality improvement efforts."
FDA Warns Users on Proper Storage of Blood-Thinning Drug Pradaxa
NASDAQ (03/29/11) Dooren, Jennifer Corbett
The FDA has issued a warning to patients taking dabigatran etexilate mesylate (Pradaxa). According to the warning, this product should be kept in its original bottle or blister pack rather than moving it to a separate storage container. Failure to do so may reduce the drug's potency. The product label and medication guide for the drug discuss proper storage and handling, but the agency is concerned that the requirements are not being followed by users or by pharmacies. The FDA also said patients taking the drug are instructed to discard any unused pills after 30 days, although new findings suggest the drug maintains its potency up to 60 days after bottle opening as long as it is stored in the original bottle and the handling requirements are met.
Psychologists Seek Authority to Prescribe Psychotropic Medications
Washington Post (03/21/11) Andrews, Michelle
Some studies have shown, that although more than a quarter of U.S. adults have a diagnosable mental health problem, fewer than half of those diagnosed receive treatment. If they do receive care, often patients will obtain it through their primary-care physician rather than a mental health professional. "It’s a huge access issue," says Katherine Nordal, executive director for professional practice at the American Psychological Association. Psychologists have suggested that, in order to improve access to treatment, they should have more authority to prescribe psychotropic medications. New Mexico and Louisiana already allows them to do so, as well as in all branches of the military and the Indian Health Service. Several other states are considering measures that would give psychologists additional prescribing authority. While any medical doctor can prescribe psychotropic drugs, psychologists must complete work equivalent to an additional master’s degree in clinical psychopharmacology.
Most Parents Trust Vaccine Information They Get From Doctors, U-M Study Finds
Grand Rapids Press (MI) (04/02/11) Thoms, Sue
Researchers at the University of Michigan report findings that most parents obtain their information about vaccines from their children's doctors, but other sources of information include friends, family members, and even celebrities. "Even if only a fraction of parents receive, believe and act on misinformation about vaccine safety provided by these different sources, individual children's health and the population's health may suffer because of vaccine-preventable illnesses," said Dr. Gary Freed, chief of general pediatrics at the University of Michigan's school of public health. This study is published in the journal Pediatrics. The researchers surveyed 1,552 parents of children aged 17 years and younger. When asked whom they trusted "a lot" for vaccine information, 76 percent of respondents said they trusted their child's doctor, 26 percent trusted other healthcare providers, and 23 percent trusted government vaccine experts. When asked who they put "some" trust in, 67 percent said family and friends.
|
April 2011
Sponsored by:
Amgen Inc. GNYHA Services, Inc. Millennium Pharmaceuticals
About NJSHP
To be visibly engaged in the enhancement of healthcare through professional development of our members in the practice of pharmacy.
New Jersey Society of Health-System Pharmacists
760 Alexander Rd
P.O. Box 1
Princeton, NJ 08543-0001
(609) 936-2205
• e-mail link About ASHP
ASHP is a 35,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP is the only national organization of hospital and health-system pharmacists and has a long history of improving medication use and enhancing patient safety.
American Society of Health-System Pharmacists
7272 Wisconsin Avenue
301-657-3000
Bethesda, MD 20814 • e-mail link Calendar
|
||||
| |||||
